Learn / ALVO
NASDAQ: ALVO
Alvotech (ALVO) stock, explained like you're 5
Alvotech trades on the Nasdaq under the ticker ALVO. It is a mid cap company in the biological products (no diagnostic substances) industry, part of the healthcare sector, with a market value of about 2.3 billion dollars.
- Ticker
- ALVO
- Exchange
- Nasdaq
- Sector
- Healthcare
- Industry
- Biological Products (No Diagnostic Substances)
- Size
- Mid cap, about 2.3 billion dollars
Is Alvotech a small, medium or large cap company?
No. Alvotech is a mid cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 2.3 billion dollars.
Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.
How Alvotech makes money
- Selling medicines, medical devices or healthcare services.
- Insurance premiums or hospital and clinic fees.
- Research and licensing deals.
What moves ALVO stock
- Results from clinical trials and approvals from regulators.
- Drug prices, insurance rules and government policy.
- Patents running out and new competing treatments.
In the news lately
- Alvotech Stock In Focus After Europe Filing For Eylea 8 Mg Copycat (Yahoo Finance)
- Alvotech (ALVO) Climbed, But What Is Behind The Latest Attention? (Simply Wall Street)
- Alvotech, Advanz Submit First Eylea 8 mg Biosimilar Bid (BioPharm International)
- Alvotech (NASDAQ:ALVO) Stock Has Consensus Target Price of $8.50 According to Brokerages (MarketBeat)
- A proposed Eylea biosimilar remains unapproved as Alvotech (ALVO) submits its European application. (Stock Titan)
Follow ALVO in your daily brief
Each trading day at 5 PM ET we post what happened to Alvotech and why it matters, in simple words. Free.
Start my free briefKey terms to know before you follow ALVO
Questions about Alvotech stock
What does Alvotech do?
Alvotech trades on the Nasdaq under the ticker ALVO. It is a mid cap company in the biological products (no diagnostic substances) industry, part of the healthcare sector, with a market value of about 2.3 billion dollars.
What is the ticker symbol for Alvotech?
Alvotech trades under the ticker ALVO on the Nasdaq.
What is Alvotech's market cap?
Alvotech is a mid cap stock with a market cap of about 2.3 billion dollars.
How does Alvotech make money?
Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.
What moves ALVO stock?
Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.
How can I follow ALVO stock every day?
Add ALVO to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.
Similar stocks
Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.